Advertisement
BD Biosciences
BD Biosciences

Supreme Court Rejects Stem Cell Case

The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.

By | January 8, 2013

WIKIMEDIA, NISSIM BENVENISTYMore than 3 years after the legality of federal funding for human embryonic stem cell (hESC) research was challenged in the courtroom, the US Supreme Court yesterday (January 7) decided not to hear the case. The high Court’s decision means that a lower court’s dismissal of the case will stand, and that federal hESC funding can continue.

The case started in 2009, after President Barack Obama issued a federal order to allow new hESC lines to be funded by federal grants. Two adult stem cell researchers objected to the new order and brought a case arguing that the new National Institutes of Health (NIH) guidelines stemming from this order violated the Dickey-Wicker Amendment, which prohibits federal funding for any research involving the destruction of human embryos. The case went through several courts before the plaintiffs filed a 36-page petition, known as a writ of certiorari, with the US Supreme Court.

(Hat tip to The Chronicle of Higher Education)

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Simulating Scientific Sabotage, For Fun
  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Advertisement
Life Technologies